All News

    Cabometyx Combo Maintains Progression-Free Survival Benefit in Advanced RCC

    February 15th 2025, 8:54pm

    Article

    Final results were consistent with previously conducted research in patients with advanced renal cell carcinoma treated with Cabometyx, Opdivo and Yervoy.

    Antitumor Activity Elicited in ccRCC Following Lenvima/Welireg Treatment

    February 15th 2025, 8:43pm

    Article

    Among patients with clear cell renal cell carcinoma, improved responses were observed with Lenvima plus Welireg versus Keytruda plus Lenvima.

    FDA-Approved Fotivda Dose More Effective Than Reduced Dose in RCC

    February 15th 2025, 8:04pm

    Article

    Researchers showed that 1.34 mg of Fotivda provided decreased tumor size and may be more tolerable than an 0.89-mg dose among patients with renal cell carcinoma.

    Bavencio Has Efficacy in The Real-World Treatment of Urothelial Cancer

    February 15th 2025, 6:00pm

    Article

    Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.

    Padcev Significantly Improves OS in Real-World Urothelial Carcinoma

    February 15th 2025, 5:25pm

    Article

    Among patients in the real world with unresectable or metastatic urothelial carcinoma, Padcev significantly improved overall survival outcomes.

    Understanding How One Must Interpret PSA Levels in Prostate Cancer

    February 14th 2025, 10:00pm

    Video

    Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression.

    Padcev Plus Keytruda Shows Promise for Upper Tract Urothelial Carcinoma Lesions

    February 14th 2025, 9:32pm

    Article

    Results from a small retrospective analysis of patients with upper tract urothelial carcinoma lesions were shared at the 2025 ASCO Genitourinary Cancers Symposium.

    High Omega-3 Diet With Fish Oil Reduces Ki-67 Index in Prostate Cancer

    February 14th 2025, 9:10pm

    Article

    Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.

    Neuropathy, Rash, Hyperglycemia Linked to PFS in Urothelial Carcinoma

    February 14th 2025, 7:30pm

    Article

    Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in metastatic urothelial carcinoma.

    Padcev May Be Safe in Older Patients With Bladder Cancer

    February 14th 2025, 6:35pm

    Article

    Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, a type of bladder cancer.